StonvexLoading…
StonvexStonvexStonvexCore line items from OPTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $28.08M | $28.45M | $29.44M | $27.84M |
Operating Income | $-517.60K | $-2.58M | $1.54M | $-528.23K |
Net Income | $-1.79M | $-2.48M | $1.98M | $-434.57K |
EPS (Diluted) | $-0.05 | $-0.07 | $0.06 | $-0.01 |
Total Assets | $24.31M | $26.01M | $26.55M | $22.46M |
Total Liabilities | $14.77M | $14.97M | $13.48M | $13.00M |
Cash & Equivalents | $358.87K | $598.79K | $2.16M | $117.51K |
Free Cash Flow OCF − CapEx | $28.34K | $-2.18M | $871.04K | $687.08K |
Shares Outstanding | 36.92M | 36.69M | 36.69M | 31.60M |